Literature DB >> 2822302

Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone.

I Todd1, R Pujol-Borrell, L J Hammond, J M McNally, M Feldmann, G F Bottazzo.   

Abstract

HLA Class II molecules are expressed by human thyroid epithelial cells (thyrocytes) in thyroid autoimmunity, although these cells are normally Class II-. gamma-Interferon (gamma-IFN) is probably involved in this expression, as suggested by its ability to induce Class II in cultured normal thyrocytes. We have now found that thyroid stimulating hormone (TSH) enhances Class II expression induced in cultured thyrocytes by gamma-IFN, and effects similar to those of TSH were obtained with dibutyryl cyclic AMP. A proportion of thyrocytes also expressed Class II following treatment with TSH or dibutyryl cyclic AMP in the absence of gamma-IFN, but the optimal activity of these mediators then appeared to be dependent upon the occurrence of some pre-existing Class II expression. These findings give insights into how a variety of mediators may influence Class II expression in thyroid autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822302      PMCID: PMC1542364     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Serum thyroid hormone and thyrotropin levels in subjects from endemic goiter regions of New Guinea.

Authors:  I J Chopra; J M Hershman; R W Hornabrook
Journal:  J Clin Endocrinol Metab       Date:  1975-02       Impact factor: 5.958

2.  Interferon-mediated enhancement of thyroid major histocompatibility complex antigen expression. A flow cytometric analysis.

Authors:  D C Rayner; P M Lydyard; H J de Assis-Paiva; S Bidey; P van der Meide; A M Varey; A Cooke
Journal:  Scand J Immunol       Date:  1987-06       Impact factor: 3.487

3.  Diet and antibody response to vaccinations in healthy infants.

Authors:  G Zoppi; R Gasparini; F Mantovanelli; L Gobio-Casali; R Astolfi; P Crovari
Journal:  Lancet       Date:  1983-07-02       Impact factor: 79.321

4.  The synergistic anti-proliferative effect of gamma-interferon and human lymphotoxin.

Authors:  S H Lee; B B Aggarwal; E Rinderknecht; F Assisi; H Chiu
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

5.  Modulation by thyrotropin of thyroglobulin synthesis in cultured thyroid cells : correlations with polysome profile and cytoplasmic thyroglobulin mRNA content.

Authors:  O Chabaud; J Chebath; A Giraud; J Mauchamp
Journal:  Biochem Biophys Res Commun       Date:  1980-03-13       Impact factor: 3.575

6.  Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.

Authors:  T Hanafusa; R Pujol-Borrell; L Chiovato; R C Russell; D Doniach; G F Bottazzo
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

7.  Flow microfluorimetric analysis of autoantibody reactions with parietal cell surface membranes in pernicious anaemia.

Authors:  H J De Aizpurua; B Ungar; B H Toh
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

8.  Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells.

Authors:  M Londei; J R Lamb; G F Bottazzo; M Feldmann
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

9.  Immunological features of nonimmunogenic hyperthyroidism.

Authors:  B Grubeck-Loebenstein; K Derfler; H Kassal; W Knapp; K Krisch; K Liszka; P P Smyth; W Waldhäusl
Journal:  J Clin Endocrinol Metab       Date:  1985-01       Impact factor: 5.958

10.  Human lymphocyte production of immunoreactive thyrotropin.

Authors:  E M Smith; M Phan; T E Kruger; D H Coppenhaver; J E Blalock
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

View more
  10 in total

1.  Epidermal growth factor and transforming growth factor-alpha suppress HLA class II induction in human thyroid epithelial cells.

Authors:  I Todd; L J Hammond; R F James; M Feldmann; G F Bottazzo
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

2.  Suppression of HLA class II expression on thyrocytes by interferon-alpha 1.

Authors:  V Guerin; I Todd; L J Hammond; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

3.  HLA-DMB expression by thyrocytes: indication of the antigen-processing and possible presenting capability of thyroid cells.

Authors:  Z Wu; P A Biro; R Mirakian; L Hammond; F Curcio; F S Ambesi-Impiombato; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

4.  HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro.

Authors:  I Todd; R Pujol-Borrell; B A Abdul-Karim; L J Hammond; M Feldmann; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

5.  Cytokine regulation of HLA on thyroid epithelial cells.

Authors:  K Migita; K Eguchi; T Otsubo; A Kawakami; H Nakao; Y Ueki; C Shimomura; A Kurata; T Fukuda; M Matsunaga
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

6.  The expression of the microsomal/peroxidase autoantigen in human thyroid cells is thyrotrophin-dependent.

Authors:  L Chiovato; P Vitti; P Cucchi; C Mammoli; P Carajon; A Pinchera
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

7.  The role of interferon-gamma in lymphocytic thyroiditis: its functional and pathological effect on human thyrocytes in culture.

Authors:  A W Kung; L Ma; K S Lau
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

8.  Effect of cytokines on HLA-DR and IL-1 production by a monocytic tumour, THP-1.

Authors:  G Portillo; M Turner; D Chantry; M Feldmann
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

Review 9.  Role of apoptosis in autoimmunity.

Authors:  Matilde Todaro; Ann Zeuner; Giorgio Stassi
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.542

Review 10.  Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher.

Authors:  Daniela Gallo; Eliana Piantanida; Matteo Gallazzi; Luigi Bartalena; Maria Laura Tanda; Antonino Bruno; Lorenzo Mortara
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-17       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.